Congenica News and Activities

View the org chart displaying its 12 main executives

Most searched biographies at Congenica

• Rob Denison, Chief Executive Officer and Director
• Andy Richards, Chairman of the Board
• Michael Anstey, Non-Executive Director

Popular executive movements at Congenica

• Eleni Salamaxani, Director, Sales, United Kingdom, has left the company  (posted on January 26 2026).
• Bob Vaughan, Director, Data and Informatics, has left the company  (posted on October 20 2025).
• Helen Savage, Acting Chief Scientific Officer, has left the company  (posted on October 20 2025).

Create your alert
to follow the executive moves at Congenica.

Congenica has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Congenica

• Recent Posts | News (11)

Social media about Congenica

• Congenica on Wikipedia, Google News & Yahoo Finance
• Congenica on LinkedIn, X (Twitter) & YouTube